QMAX Trademark

Pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, impotence, low libido, diminished sexual arousal, premature ejaculation, delayed ejaculation, ejaculatory dysfunction, orgasmic disorders, and disorders of male sexual performance and desire in men; pharmaceutical preparations for improving sexual stamina, male libido, blood flow and sexual arousal in men; pharmaceutical preparations for enhancing male sexual performance; pharmaceutical preparations for daily use in the treatment of erectile dysfunction and male sexual health conditions; pharmaceutical preparations, namely, phosphodiesterase type 5 inhibitors for erectile dysfunction and dopamine agonists for sexual dysfunction and low libido; compounded pharmaceutical preparations for erectile dysfunction and sexual dysfunction, including in sublingual liquid form; pharmaceutical preparations in oral, sublingual, orally disintegrating tablet, troche, lozenge, chewable tablet, dissolvable oral, topical, and injectable dosage forms for erectile dysfunction and sexual dysfunction; pharmaceutical preparations in the nature of a 4-in-1 combination formula for erectile dysfunction and male sexual health conditions; none of the foregoing being dietary supplements or nutritional supplements; all of the foregoing excluding dietary supplements, nutritional supplements, and nutraceutical preparations for prostate health, bladder health, urinary function, and heart health; all of the foregoing primarily dispensed by a licensed healthcare provider; providing health information in the field of erectile dysfunction and male sexual health; telehealth services, namely, clinical evaluation, treatment planning, medical consultations, and prescribing for erectile dysfunction and male sexual health conditions via an online telecommunications platform